Laboratory Corporation of Ameri Price Today
Laboratory Corporation of Ameri
LH
Healthcare
$19.07B
💰
Market Cap
19.3
💸
Price to Earnings
$11.1
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
12 |
Strong Buy |
8 |
Hold |
5 |
Sell |
0 |
Strong Sell |
0 |
LH Price Forecast Target
215.2 👉 290.0 +35%
LH EPS Forecast
11.1 👉 15.0 +35%
Financials
Profit Margin
6 %
Revenue Growth
-17.9 %
Dividend
$ 2.88
Held Percent
0.3% - Insiders
93.3% - Institutions
6.4% - Public
Major Fund Holders
-
💰 Blackrock Inc. $2.7B
-
💰 Vanguard Group Inc $2.4B
-
💰 State Street Corporation $902.6M
-
💰 Wellington Management Group, LLP $619.7M
-
💰 Geode Capital Management, LLC $422.8M
Stock Ideas
Daniel Sundheim Portfolio
Daniel Sundheim is the founder of D1 Capital Partners, a renowned multi-billion dollar global investment firm. Prior to starting his own firm, Sundheim worked as a portfolio manager at prestigious hedge funds before breaking out on his own in 2018. …Larry Robbins Portfolio
Larry Robbins is a successful hedge fund manager who founded Glenview Capital in 2001 after working as a trader at Omega Advisors. His portfolio strategy has led to impressive returns, with Glenview Capital returning 301% after fees and expenses bet…Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…Paul Tudor Jones Portfolio
Paul Tudor Jones is a pioneer in macro trading and founder of Tudor Investment Corporation, one of the earliest pioneering hedge funds. With over 40 years of experience investing across global markets, Jones strategically allocates capital based on …📮FAQ
Some Frequently Asked Questions.
The Laboratory Corporation of Ameri industry is Diagnostics & Research
The Laboratory Corporation of Ameri sector is Healthcare
The Laboratory Corporation of Ameri forecasted predicted Price to Earnings PE ratio is 14.4
The Laboratory Corporation of Ameri Price to Earnings PE ratio is 19.3
The Market Capitalization of Laboratory Corporation of Ameri is $19.07B
There are total of 88393098 float shares with 93.3% held by Institutions and 0.3% held by insiders
The MLaboratory Corporation of Ameri forecasted Earnings per Share EPS is $15.0
The Laboratory Corporation of Ameri Earnings per Share EPS is 11.1
The Laboratory Corporation of Ameri company has $4385100000 gross profits with 6 profit margins
The Laboratory Corporation of Ameri Earnings Growth is -0.452% with -0.473% quarterly earnings growth
The Laboratory Corporation of Ameri Revenue is $14880799744 with -0.179 revenue growth
The price target for Laboratory Corporation of Ameri stock is $290.0 for the high target and $215.0 for the low target
The consensus analyst recommendations for Laboratory Corporation of Ameri is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Laboratory Corporation of Ameri is Buy, with the following breakdown:
- Buy: 12
- Strong Buy: 8
- Hold: 5
- Sell: 0
- Strong Sell: 0
The Beta of Laboratory Corporation of Ameri is 1.1
The dividend of Laboratory Corporation of Ameri is $2.88
The dividend yield of Laboratory Corporation of Ameri is 0.0135%
The biggest institutional and mutual fund holders of Laboratory Corporation of Ameri stock are
- Blackrock Inc.
- Vanguard Group Inc
- State Street Corporation
- Wellington Management Group, LLP
The Laboratory Corporation of Ameri ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0